Home
>
National Drug Code (NDC)
>
Levothyroxine Sodium
Levothyroxine Sodium - 63323-647-10 - (LEVOTHYROXINE SODIUM)
Drug Information of Levothyroxine Sodium
| Product NDC: | 63323-647 |
| Proprietary Name: | Levothyroxine Sodium |
| Non Proprietary Name: | LEVOTHYROXINE SODIUM |
| Active Ingredient(s): | 200 ug/5mL & nbsp; LEVOTHYROXINE SODIUM |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Levothyroxine Sodium
| Product NDC: | 63323-647 |
| Labeler Name: | APP Pharmaceuticals, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA202231 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20110624 |
Package Information of Levothyroxine Sodium
| Package NDC: | 63323-647-10 |
| Package Description: | 1 VIAL, SINGLE-USE in 1 CARTON (63323-647-10) > 5 mL in 1 VIAL, SINGLE-USE |
NDC Information of Levothyroxine Sodium
| NDC Code | 63323-647-10 |
| Proprietary Name | Levothyroxine Sodium |
| Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (63323-647-10) > 5 mL in 1 VIAL, SINGLE-USE |
| Product NDC | 63323-647 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | LEVOTHYROXINE SODIUM |
| Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20110624 |
| Marketing Category Name | NDA |
| Labeler Name | APP Pharmaceuticals, LLC |
| Substance Name | LEVOTHYROXINE SODIUM |
| Strength Number | 200 |
| Strength Unit | ug/5mL |
| Pharmaceutical Classes | l-Thyroxine [EPC],Thyroxine [Chemical/Ingredient] |
